J and J Snack Foods News

Cancer patients who took drugs to cut the risk of anemia were twice as likely to develop blood clots in the lungs or legs as other patients, a decade-long study of more than 55,000 cancer patients has found.

J&J Snack Foods Corp. posted a 3 percent increase in sales for the fourth quarter and a 32 percent spike in earnings for the same period a year ago.

Posted on November 3, 2009 @ 09:48 am Kenneth A. Berlin has been appointed president and chief executive officer, Rosetta Genomics, Ltd.

What does Warren E. Buffett see in railroads? Berkshire Hathaway , his investment company, is paying a big premium for Burlington Northern Santa Fe .

AstraZeneca has launched a blog - AZ Health Connections - and the critics don't like it.

The scariest wrinkle in the Omnicare kickback case is just how vulnerable old people in nursing homes are to schemes in which drug companies allegedly induce pharmacies to prescribe drugs they otherwise wouldn't. Download the complaint from the Phillips and Cohen web site .

Abbott Laboratories failed to convince a federal judge to throw out a record $1.67 billion verdict won by Johnson & Johnsona s Centocor unit in a suit over an arthritis drug patent.

November 04, 2009 - Comments With the Q3 2009 earnings season in the rearview mirror, I can say my prediction was off the mark: The job situation at ad agencies is actually a lot worse than it looked before the U.S. holding companies made their earnings releases.

Warren Buffett's Berkshire Hathaway Inc will pay $26 billion to buy out Burlington Northern Santa Fe Corp in a bet that the nation's largest rail company is... ... More The U.S. Food and Drug Administration is moving quickly to use its sweeping new tobacco powers despite facing swift legal action from cigarette makers.

As a result, J&J expects to save at least $800 million next year and $1.4 billion or more annually, starting in 2011.

The nation's largest nursing home pharmacy, Omnicare Inc. of Covington, Kentucky, will pay $98 million, and drug manufacturer, IVAX Pharmaceuticals of Weston, Florida, will pay $14 million to resolve allegations that Omnicare engaged in kickback schemes with several parties, including IVAX, the Justice Department announced today.

Johnson & Johnson, the world's biggest health-care company, will lay off six to seven percent of its workforce in a restructuring designed to eliminate layers of management.

Johnson & Johnson said on Tuesday it plans to cut 6 percent to 7 percent of its workforce in a battle to prop up profits in the face of generic competition to its prescription drugs.

Johnson & Johnson's CEO has given an interview to the Financial Times explaining his company's strategy with acquisitions.

Johnson & Johnson , the US healthcare group, will in future take more long-term minority stakes and forge alliances with rival pharmaceuticals companies in an effort to share the rising costs and risks of drug development.

Investors are finding encouragement from the latest batch of earnings reports. Stocks rose in early trading Wednesday after a handful of banks, including Morgan Stanley, US Bancorp and Wells Fargo, posted better results for the July-September quarter.

Shares in drugmaker Elan gained as much as 4.5pc in Dublin trading yesterday after the company reported a third-quarter profit and raised its full-year adjusted earnings forecast.

State, county and municipal entities across the nation enjoy a privileged position in the debt markets -- the interest they pay is often tax-free and their market is lightly regulated.

Miracles do happen. This 2007 SAP-PM implementation for a bulk biopharmaceutical manufacturer has paid for itself through savings in both material and time.

To appreciate the impact of crisis project management, it's important to understand how the discipline started.